dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
Published 4 years ago • 110 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
2:22
dr. konecny on the value of parp inhibitors in ovarian cancer
-
1:14
dr. copeland on the use of parp inhibitors in ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
1:41
dr. parsons discusses the role of parp 7 in overall survival of patients with ovarian cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
0:41
understand the adverse events of parp inhibitors